{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_15292", "batch_size": 200, "batch_pos": 170, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain high-potency verbs, potent metaphors, superlatives + negative nouns, or critical alert phrases.", "method": "llm_batch", "batch_id": "batch_2_18536", "batch_size": 200, "batch_pos": 120, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment describes uncertainty about future manufacturing, not realised impact.", "method": "llm_batch", "batch_id": "batch_3_4688", "batch_size": 200, "batch_pos": 62, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a question.", "method": "llm_batch", "batch_id": "batch_4_320", "batch_size": 200, "batch_pos": 39, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Lacks explicit calming language or keywords.", "method": "llm_batch", "batch_id": "batch_5_18488", "batch_size": 200, "batch_pos": 35, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser combined with a scale contrast for reassurance.", "method": "llm_batch", "batch_id": "batch_6_12600", "batch_size": 200, "batch_pos": 2, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "Segment does not contain a bare negation.", "method": "llm_batch", "batch_id": "batch_7_18384", "batch_size": 200, "batch_pos": 188, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "no", "rationale": "Factual information about a limitation/uncertainty regarding capability, not a positive capability statement.", "method": "llm_batch", "batch_id": "batch_8_13044", "batch_size": 200, "batch_pos": 174, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 9, "answer": "no", "rationale": "The segment discusses manufacturing capacity but states it's 'too early to tell', not reporting a specific metric.", "method": "llm_batch", "batch_id": "batch_9_4688", "batch_size": 200, "batch_pos": 20, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 10, "answer": "no", "rationale": "The segment speculates about future manufacturing capacity, not relief from the threat itself.", "method": "llm_batch", "batch_id": "batch_10_18112", "batch_size": 186, "batch_pos": 48, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 11, "answer": "no", "rationale": "Attributed statement is neutral, discussing manufacturing timelines.", "method": "llm_batch", "batch_id": "batch_11_15988", "batch_size": 179, "batch_pos": 43, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 12, "answer": "yes", "rationale": "Factual report on manufacturing status.", "method": "llm_batch", "batch_id": "batch_12_18216", "batch_size": 179, "batch_pos": 43, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
